Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ANDA Approval Decline Continues, But Why?
Ongoing COVID-19 Disruptions Cited As Possible Cause
Jul 30 2021
•
By
Derrick Gingery
What does the decline in ANDA approvals and complete response letters issued say about the FDA generics program? • Source: Alamy
More from Generics
More from Products